When will winner be announced? 

Winners will be announced during the Pharma Awards Europe 2022, 17 November, 8 Northumberland Avenue, London.

Award timings are as follows (GMT)

Drinks reception: 13:00 – 14:00

Lunch: 14:00 – 15:30

Awards: 15:30 – 17:00

Networking: 17:00

Closes: 19:00

If we can’t attend, will we be disqualified? 

No. But we recommend you have someone there to accept the award on your behalf. 

Do we have to register for the awards? 

Yes, all finalists who want to see whether they have won need to register.  Please contact mohamed.farah@thomsonreuters.com for more information  

Can I request table? 

Space is scheduled on a first come, first serve basis and VIP table holders have the priority. 

What is the dress code? 

Dress to impress- Cocktail/Black Tie

What's on the menu? 

The menu will be sent through an email a few weeks before the ceremony. Please make sure you provide your dietary requirements by responding to that email.  

Will there be drinks on the night? 

Yes, your table includes drinks throughout the night, including welcome reception, throughout the ceremony and after show party. Only VIP packages get champagne upgrades. 

Will you be providing marketing? 

All finalists are part of our marketing campaign. VIP table holders and sponsors receive an extensive marketing campaign and exposure, including internal emails to Reuters Events Pharma database.

Who can enter the awards? 

All nominees or co-nominees must be currently employed in a pharmaceutical, medical device, diagnostic or biotech company.

Entries will only be accepted from vendors, solution providers or consultants if the project they are entering is in association with a pharmaceutical, medical device, diagnostic or biotech company.

We will only accept projects within the time period of January 2022 – September 2023

Check out the sample Entry Form here

What are the categories?

There are 6 award categories:

Entry Pricing

Open for Entries- 10th November 2023

Deadline to Enter - 23rd February 2024

Finalists revealed - 22nd March 2024

Winner revealed - 26th March

The finalists will feature in a mini report produced by Reuters Events that will showcase the finalist’s entries. The report will be shared to the Reuters Events Pharma database and on their social media channels.  The winners will be announced live on stage at the flagship event in Barcelona and will be invited to be the guests of honour at the finalist and winners dinner.

What are the category criteria?

Each category has specific criteria.  Under each category, there is a list of bullet points which your project needs to demonstrate in the nominations form on the submission site. Please refer to the full category description as this is what the judges will be basing their final opinions on.

1. Patient Champion Award - Pharma

The winner of this award will be an individual who has demonstrably worked to reduce patient burden from within a pharmaceutical company, and/or champion a patient community or cause. The winner should be able to show how their actions have advanced benefits to patients or amplified the patient voice within the business; they may be in a patient-facing role or be a ‘back-office ‘unsung hero’ who has driven change that will ultimately address unmet patient needs.

Criteria:
• To what extent has the candidate gone beyond the normal course of business to make an impact on the lives of patients? 
• How well has the candidate managed to overcome any challenges that they may have been faced with? 
• How well does the candidate exhibit general leadership qualities or principles that include patient value, healthcare influence, education/awareness and commercial benefits for pharma? 
• To what extent did the actions of the nominee create positive change for patients, and/or caregivers? What is the scale of impact? 
• How sustainable is the impact of the actions that the candidate has taken to create positive change for patients, and/or caregivers? 

2. Valuable Medical Education/Awareness Initiative Award

This award is for an initiative that has raised the profile and visibility of a disease, cause, health concern, population or treatment. We are not looking to reward mere advertising (no matter how good it is); we are seeking campaigns which have provided additional value, shown creative ways to raise awareness, gathered further reach in an additional way, clarified scientific concepts for HCPs or patients, or made things easier or clearer. Ultimately, we are looking for an authentic effort to educate and further the understanding of something that matters, and that has achieved success in doing so. 

Criteria:
• To what extent did the team manage to define and connect with an underlying unaddressed issue?  
• Once the project was initiated, how would you evaluate the quality of the team’s approach to understand real health requirements prior to implementation? 
• To what extent was a creative approach demonstrated to foster better engagement, learning and understanding? 
• How successful has this initiative been to date? Does the project show demonstrated impact?  
• How sustainable is this initiative? Will long-term impact be created, or will impact be created that goes beyond the initial target issue? 
 

3. Most Valuable Digital Patient Engagement Award

The winner of this award will be a project or initiative that has advanced patient outreach and engagement, through digital approaches, post launch (including digital health efforts). It should demonstrate an iterative approach to product development by identifying and addressing real health requirements prior to and during implementation. The winning project will have met a strong patient need and been managed to an outstanding level, making a quantifiable, positive impact on patients.

Criteria:
• How well did the project ensure it understood patient-preferred engagement prior to implementation? 
• To what extent did the project demonstrate a quantifiable positive impact on the patient population identified as it serving?
• How sustainable is the project? To what extent will the project ensure long-term impact for the intended customer? 
• To what extent did the project apply an iterative, agile approach to gathering and applying patient feedback?
• To what extent was the project accessible to diverse patient demographics? (social, econ, racial, age)
 

4. Driving Health Equity Award

The winner of this award will be an initiative which has demonstrably worked to deliver on driving equitable access for patients in underserved communities – such includes but is not limited to educational programs, outreach and awareness campaigns, advocacy partnership or research studies that helped to dismantle societal barriers to equitable medicine use.

Criteria 
• To what extent did the project/initiative identify and understand previously unmet patient needs, prior to and during implementation?
• To what extent has the candidate gone beyond the normal course of business to enable equitable access? 
• To what extent did the project demonstrate a quantifiable positive impact on access patients in underserved communities?  
• How successful has this initiative been to date? Does the project show demonstrated impact?  
• How sustainable is this initiative? Will long-term impact be created, or will impact be created that goes beyond the initial target issue? 
 

5. Best brand launch campaign

This award recognizes the launch of a new product or service to the market. This could include a digital campaign, launch event, PR, social media etc. The nominee must demonstrate an understanding of the audience and an effective use of the medium to engage with the end user. This category is open to both in-house teams and agencies.

Criteria 
• To what extent has this launch demonstrated originality, innovation and creativity?
• How has the launch understood the client’s (or companies) strategy, needs and aspirations for the product?
• To what extent has the company demonstrated an understanding of the target audience
• How effectiveness was the campaign?  – ROI, product engagement, reach

6. Sustainability Award

The winner of this award will be leading an initiative that moves pharma closer to becoming an industry at the forefront of sustainability efforts.  The initiative will demonstrate ambitious goals as well as detailed plans to achieve them. The initiative will also encapsulate changes already implemented by the company, that have had a positive impact on the sustainability of the business.

Criteria 
• To what extent did the initiative address a sustainability problem?
• To what extent is the initiative ambitious and go beyond the industry standard?
• What tangible outcomes are already evident from the initiative?
• To what extent has the project got a convincing strategy to scale? 
• To what extent will this project have sustained impact?